Skip to content

Arcutis Biotherapeutics Inc (ARQT) Reports Significant Revenue Growth in Q4 2023

  • by
  • 1 min read

Robust Demand for ZORYVE Cream Drives 357% Year-Over-Year Increase

Join the conversation

Your email address will not be published. Required fields are marked *